Associations of risk factors of e-cigarette and cigarette use and susceptibility to use among baseline PATH study youth participants (2013-2014).


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
04 2019
Historique:
received: 03 05 2018
revised: 16 11 2018
accepted: 16 11 2018
pubmed: 27 11 2018
medline: 17 6 2020
entrez: 27 11 2018
Statut: ppublish

Résumé

Improved understanding of the distribution of traditional risk factors of cigarette smoking among youth who have ever used or are susceptible to e-cigarettes and cigarettes will inform future longitudinal studies examining transitions in use. Multiple logistic regression analysis was conducted using data from youth (ages 12-17 years) who had ever heard of e-cigarettes at baseline of the PATH Study (n = 12,460) to compare the distribution of risk factors for cigarette smoking among seven mutually exclusive groups based on ever cigarette/e-cigarette use and susceptibility status. Compared to committed never users, youth susceptible to e-cigarettes, cigarettes, or both had increasing odds of risk factors for cigarette smoking, with those susceptible to both products at highest risk, followed by cigarettes and e-cigarettes. Compared to e-cigarette only users, dual users had higher odds of nearly all risk factors (aOR range = 1.6-6.8) and cigarette only smokers had higher odds of other (non-e-cigarette) tobacco use (aOR range = 1.5-2.3), marijuana use (aOR = 1.9, 95%CI = 1.4-2.5), a high GAIN substance use score (aOR = 1.9, 95%CI = 1.1-3.4), low academic achievement (aOR range = 1.6-3.4), and exposure to smoking (aOR range = 1.8-2.1). No differences were observed for externalizing factors (depression, anxiety, etc.), sensation seeking, or household use of non-cigarette tobacco. Among ever cigarette and e-cigarette users, dual users had higher odds of reporting traditional risk factors for smoking, followed by single product cigarette smokers and e-cigarette users. Understanding how e-cigarette and cigarette users differ may inform youth tobacco use prevention efforts and advise future studies assessing probability of progression of cigarette and e-cigarette use.

Identifiants

pubmed: 30473246
pii: S0306-4603(18)31336-4
doi: 10.1016/j.addbeh.2018.11.027
pmc: PMC7416532
mid: NIHMS1606460
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-60

Subventions

Organisme : NIDA NIH HHS
ID : HHSN271201100027C
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 DA999999
Pays : United States

Informations de copyright

Published by Elsevier Ltd.

Références

Pediatrics. 2017 Jun;139(6):
pubmed: 28562266
Drug Alcohol Depend. 2017 May 1;174:209-214
pubmed: 29350617
MMWR Morb Mortal Wkly Rep. 2017 Jun 16;66(23):597-603
pubmed: 28617771
PLoS One. 2018 Mar 14;13(3):e0193328
pubmed: 29538396
Tob Control. 2017 Jul;26(4):371-378
pubmed: 27507901
Health Rep. 2012 Mar;23(1):47-53
pubmed: 22590805
Am J Addict. 2006;15 Suppl 1:80-91
pubmed: 17182423
Pediatrics. 2015 Jan;135(1):e43-51
pubmed: 25511118
J Psychiatr Res. 2016 Feb;73:71-8
pubmed: 26688438
Addict Behav. 2018 Jul;82:79-85
pubmed: 29501011
Tob Control. 2017 Jan;26(1):34-39
pubmed: 26811353
Pediatrics. 2015 Aug;136(2):308-17
pubmed: 26216326
JAMA Pediatr. 2017 Aug 1;171(8):788-797
pubmed: 28654986
MMWR Morb Mortal Wkly Rep. 2015 Oct 02;64(38):1061-5
pubmed: 26422781
Addict Behav. 2018 Jan;76:208-217
pubmed: 28846942
J Adolesc Health. 2015 Aug;57(2):186-91
pubmed: 26206439
Health Psychol. 1996 Sep;15(5):355-61
pubmed: 8891714
J Adolesc Health. 2003 Dec;33(6):436-57
pubmed: 14642706

Auteurs

Michael D Sawdey (MD)

Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Michael.Sawdey@fda.hhs.gov.

Hannah R Day (HR)

Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.

Blair Coleman (B)

Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.

Lisa D Gardner (LD)

Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.

Sarah E Johnson (SE)

Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.

Jean Limpert (J)

Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.

Hoda T Hammad (HT)

Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.

Maciej L Goniewicz (ML)

Department of Health Behavior, Division of Cancer Prevention & Population Sciences, Roswell Park Cancer Institute, Buffalo, NY, USA.

David B Abrams (DB)

Department of Social and Behavioral Sciences, NYU College of Global Public Health, New York University, New York, NY, USA.

Cassandra A Stanton (CA)

Westat, Rockville, MD, USA; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

Jennifer L Pearson (JL)

Division of Social and Behavioral Sciences/Health Administration and Policy, University of Nevada, Reno, Reno, NV, USA.

Annette R Kaufman (AR)

Tobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.

Heather L Kimmel (HL)

National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD, USA.

Cristine D Delnevo (CD)

Department of Health Education and Behavioral Science, Center for Tobacco Studies, Rutgers School of Public Health, Piscataway, NJ, USA.

Wilson M Compton (WM)

National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD, USA.

Maansi Bansal-Travers (M)

Department of Health Behavior, Division of Cancer Prevention & Population Sciences, Roswell Park Cancer Institute, Buffalo, NY, USA.

Raymond S Niaura (RS)

Department of Social and Behavioral Sciences, NYU College of Global Public Health, New York University, New York, NY, USA.

Andrew Hyland (A)

Department of Health Behavior, Division of Cancer Prevention & Population Sciences, Roswell Park Cancer Institute, Buffalo, NY, USA.

Bridget K Ambrose (BK)

Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH